# Provider Clinical Summary (PROVIDER-ONLY)

_Decision-support summary. Not a diagnosis, treatment recommendation, or dosing guidance._

**Patient:** Robert Lee (DEMO-007)
**Status:** active · **Risk level:** Low Review Priority
**Latest assessment:** 2026-06-14T00:42:56.241014+00:00 · **Last follow-up:** 2026-03-06T09:00:00+00:00

## Clinical snapshot
- Primary phenotype: neuroinflammation
- Secondary phenotype: mitochondrial_dysfunction
- Recovery stage (derived): partial_regression — Clinical improvement score 34 (30–44 below baseline).
- Confidence: 61 (moderate)
- Top contributors: Brain fog, Short-term memory impairment, Slowed cognitive processing, Headache, Tingling / numbness (neuropathy)

## Co-infection pattern scores
- bartonella: 0
- babesia: 0
- ebv: 85
- mold_cirs: 0
- mcas: 0

## Lab system scores
- inflammatory: 27
- immune: 48
- mitochondrial: 0
- hormonal: 0
- metabolic: 0
- nutritional: 4
- detoxification: 18
- neuroinflammatory: 49
- connective_tissue: 22
- Abnormal: wbc (low), lymphocytes (high), crp (high), esr (high), vitamin d (low), ast (high), alt (high)
- Missing: 40 marker(s)

## Safety review
- Overall: 0 (Low Review Priority)
- Missing safety info: pregnancy_status_confirmed, infection_status_confirmed

## Outcomes
- Clinical improvement score: 34
- Functional improvement score: 32

## Provider review
- Status: in_progress
- Notes: Post-viral neuroinflammatory picture; declining at follow-up — re-evaluate. Worsening trend flagged.

_Generated decision-support summary — physician review required. Source documents remain the source of truth._